Page last updated: 2024-11-06

suxethonium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

suxethonium: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID46037
CHEMBL ID2111153
SCHEMBL ID487808
MeSH IDM0061659

Synonyms (15)

Synonym
med638szqb ,
suxethonium
67724-50-9
ethanaminium, 2,2'-((1,4-dioxo-1,4-butanediyl)bis(oxy)bis(n-ethyl-n,n-dimethyl-
unii-med638szqb
n,n'-(2,2'-(succinyldioxy)diethyl)bis-ethyldimethyl ammonium hydroxide
2,2'-[(1,4-dioxobutane-1,4-diyl)bis(oxy)]bis(n-ethyl-n,n-dimethylethanaminium)
ethyl(2-hydroxyethyl)dimethylammonium succinate
suxethonium ion
suxethonium [who-dd]
suxethonium cation
SCHEMBL487808
CHEMBL2111153
Q27283954
DTXSID30866398
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (14.29%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]